BioCardia completed clinical consultations with Japan's PMDA for its CardiAMP system, moving it closer to a marketing application. The filing does not report an application or approval, but completing this step is favorable progress.
This brings CardiAMP closer to a possible marketing application in Japan. The filing does not say an application has been submitted or approval granted, but completing the consultation process is progress toward that step.
Follow BioCardia, Inc. (BCDA) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BCDA